Dejnirattisai W, Huo J, Zhou D, Zahradnk J, Supasa P, Liu C, et al
Common considerations include: Candidate profile: Older adults with disrupted sleep, age-related melatonin decline, or elevated inflammatory markers are the most studied population
He serves on advisory boards and speakers panels of Novo Nordisk, Roche, Herbalife, GI Dynamics, Eli Lilly, Johnson & Johnson, Glia, Irish Life Health, Boehringer Ingelheim, Currax, Zealand Pharma, Keyron, AstraZeneca, and Rhythm Pharma
Furthermore, preliminary data indicates GLP-1 RAs might lower the risk of developing atrial fibrillation in specific heart failure patient populations
In the diabetes group, 44% gained weight and 56% maintained or lost weight
Table 1 Basic characteristics of the articles included in the meta-analysis